Multicenter Clinical Observation of Bingqing Essential Oil in the Treatment of Vascular Pathway Related Infections

Phase 1

• Conditions: Vascular Pathway Infection

• Registration Number: ITMCTR1900002408
• Lead Sponsor: The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) Patients who have been treated with regular hemodialysis for 3 months or more, who meet the diagnostic criteria of uremia stage of chronic renal failure;
(2) Infection of internal fistula: including infection of puncture point and surrounding skin, infection of surgical incision suture and skin surface-related infection of internal fistula vascular connection. The clinical manifestations are local pain, tenderness, congestion, swelling, exudation of bloody or purulent secretions, skin ulceration.
(3) Graft-related infections: infection of the puncture site and surrounding skin without involving the graft. The clinical manifestations were local pain, tenderness, congestion, swelling, exudation of hemocyanin or purulent secretion, skin ulceration at the infected site.
(4) Catheter-related infections: Catheter-related infections: Catheter-related infections: pyorrhea, swelling, induration and/or tenderness within 2 cm or so of the outlet, and exudation of local secretions increased; Catheter-related tunnel infections: redness, tenderness, fever and systemic symptoms along the catheter, and pus may flow out from the catheter-related mouth when squeezing the tunnel; and with or without catheter-related bacteremia;
(5) The age of the patients ranged from 18 to 80 years, with no gender limitation.
(6) To participate in the study with informed consent and sign the informed consent.

Exclusion Criteria

(1) Mental disorders, cognitive impairment, can not cooperate with the study smoothly; (2) coagulation dysfunction, has a significant tendency to bleed; (3) autoimmune deficiency; (4) allergic constitution or allergic to a variety of drugs; (5) poor compliance.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Safety indicators;Relevant clinical symptoms and signs scale;